As GLP-1 receptor agonists (GLP-1s) like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) become increasingly common in the treatment of diabetes, obesity, and cardiovascular disease, retina specialists are paying close attention to whether the drug therapies may influence ocular disease in already high-risk patients
Side effect comparison All three compounds share a similar gastrointestinal side effect profile, which is expected given that all three activate the GLP-1 receptor
As CoverMyMeds Mike Cohn noted, automating the repeatable parts of PA (billing info, criteria fields) removes friction and allows providers to focus on medical necessity rather than chasing paperwork ( [3] ) ( [45] )
The reviewed studies have demonstrated that a variety of interventions can be effectively utilized to ameliorate typical ASD behavioral deficits
For instance, the suggested improvement of metabolism by L-carnitine supplements is based primarily on short-term supplementation (125)